Company AnalysisAnalysis as of 11 Apr 2026

AI-generated · cited to primary sources · not investment advice · How we research

Hind. Unilever

BSE:500696
NSE:HINDUNILVR
Our Conviction
/100
Verdict locked
Mgmt
Business
Growth
Risk
Scenarios

Our verdict on Hind. Unilever isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.

See the verdict — free →
01 · Management Credibility

Does management do what it says?

ExceededGross Margin and Input Cost Correlation
94/100

The company delivered a consolidated EBITDA margin of 22.8%, which is within the guided range of 22-23%. (2 met, 3 exceeded across 5 tracked commitments)

So, our guided range has been that 22% to 23%. We also outlined that the range, therefore, you will see a benefit of the ice cream demerger to the extent of 50 basis points. ... Well, that's the implied number.

Hind. Unilever · Concall Transcript · Feb 2026 · p.23
MetOther Findings
88/100

The company operated at the higher end of its guided margin range despite stepping up A&P investments by 80 bps. (1 exceeded, 4 met across 5 tracked commitments)

Ice Cream demerger is expected to result in an improvement of 50-60 bps to the reported margin as Ice Cream business operates at a margin lower than HUL average.

Hind. Unilever · Concall Transcript · Oct 2025 · p.12

See the full cited Management analysis of Hind. Unilever

Sign up free →
02 · Business Model

How durable is the business?

Underlying Volume Growth (UVG)
80/100

Revenue share increased to 25% from 22.7%, but underlying volume declined in the low-single digits due to headwinds in Nutrition Drinks (Horlicks/Boost). (5 expanding across 1 engine)

Personal Care ₹ 2,370 cr. Revenue | 18% Margin... UVG: Low-single digit decline... Premium Skin Cleansing bars posted strong double-digit growth.

Hind. Unilever · Investor PPT · Feb 2026 · p.17
Direct Distribution Reach as Competitive Moat
80/100

The distribution moat has strengthened, now reaching over 9 million retailers across India. The company is focusing on 'Frontline marketing & sales machine' to accelerate online brand discovery and fulfillment. (1 expanding)

>9 mn retailers reached in the country ... Accelerate future-proofing of our marketing & sales capabilities

Hind. Unilever · Investor PPT · Oct 2025 · p.8

See the full cited Business Model analysis of Hind. Unilever

Sign up free →
03 · Future Growth

Where does growth come from?

D2C Brands Disrupting Legacy Categories
74/100

The D2C and 'Market Maker' portfolio is accelerating rapidly; specifically, the OZiva brand tripled its revenue year-on-year to reach a 450 cr.+ annual run rate. (5 accelerating across 5 signals, 1 leading indicator)

~ ₹ 1100 cr. ARR business between Minimalist & Oziva... Delivered strong double-digit growth in the quarter

Hind. Unilever · Investor PPT · Feb 2026 · p.10
Portfolio Premiumization and Price Tiering
71/100

HUL is successfully shifting its portfolio mix toward premium 'Future Core' and 'Market Makers,' which saw a 200 bps increase in turnover contribution. (1 accelerating, 1 new trend across 2 signals)

Accelerating premiumisation in laundry powders... Opportunity in ₹ 15,000 cr+ mass laundry market

Hind. Unilever · Investor PPT · Feb 2026 · p.10

See the full cited Future Growth analysis of Hind. Unilever

Sign up free →
04 · Risk

What could break the thesis?

Raw Material Linkage to Global Commodities
62/100

The risk is intensifying as management explicitly called out persisting inflationary pressures in Palm Oil and Skimmed Milk Powder (SMP), despite some relief in crude oil. (2 intensifying, 1 stable, 1 high-severity)

The input cost landscape has, however, remained volatile; depreciating rupee increased cost pressure on imported materials... non-feedstock commodities and sulfuric acid are inflating, impacting our Home Care portfolio.

Hind. Unilever · Concall Transcript · Feb 2026 · p.4
Gross Margin and Input Cost Correlation
59/100

The risk is intensifying as Palm Oil inflation reached +18% and Tea reached +19% in FY'25, leading to a 160 bps drop in Gross Margin for the March quarter. (3 intensifying, 1 easing, 1 stable)

EBITDA Margin DQ’25 23.3% DQ’24 24.0% -70 bps

Hind. Unilever · Investor PPT · Feb 2026 · p.14

See the full cited Risk analysis of Hind. Unilever

Sign up free →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.